Seattle, WA -- (SBWIRE) -- 10/23/2019 -- Market Overview:

Bacillus Calmette-Gurin (BCG) vaccine is the only vaccine currently available for prevention of tuberculosis (TB). In countries with high prevalence of tuberculosis, one dose is recommended for healthy babies close to the time of birth. However, in areas where tuberculosis is uncommon, only children at high risk are typically immunized, while suspected cases of tuberculosis are individually tested and treated. Adults not infected with tuberculosis and who have not been previously immunized but are frequently exposed to drug-resistant tuberculosis may be immunized as well.

The factors that drive the global BCG vaccine market include increase in prevalence of tuberculosis, especially in developing and underdeveloped countries, and technological advancement in the field of vaccine research. Moreover, the increase in government initiatives and focus on immunization programs globally further boost the market growth. Untapped market opportunities in developing regions are expected to provide numerous prospects for market development.

Download a Readymade Sample Copy of BCG Vaccine Market: https://www.worldwidemarketreports.com/sample/190177

Segment Review:

The pediatrics segment held a major share of the BCG vaccine market in 2016, and is expected to maintain its dominance throughout the forecast period. BCG is generally administered to all the infants up to one year of age in countries where BCG vaccination is a part of the national childhood immunization program. In addition, this vaccine can also be given to older children (more than 1 year of age) who have increased risk of developing tuberculosis. It is rarely given above the age of 16, and never administered above the age of 35 as vaccinations are effective only when administered in early stages of life.

Market Segmentation:

Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Immune BCG
Therapy BCG

Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Hospitals
Clinics
Others

Based on region, the report describes major regions market by products and application. Regions mentioned as follows:

Asia-Pacific
North America
Europe
South America
Middle East & Africa

Leading Key Players:

Merck & Co., Inc., Sanofi Pasteur, Japan BCG Laboratory, China National Biotec Group (a subsidiary of China National Pharmaceutical Group Corporation), Serum Institute of India Pvt. Ltd., InterVax Ltd., GreenSignal Bio Pharma Limited (GSBPL), and Statens Serum Institut.

*If you have any special requirements, please let us know and we will offer you the report as you want.

Else place an Inquire for BCG Vaccine Market Research Report: https://www.worldwidemarketreports.com/quiry/190177

About WMR
Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends.

Contact Us
Mr. Shah
Worldwide Market Reports
1001 4th Ave,
#3200
Seattle, WA 98154,
U.S
Tel: +1 415 871 0703
Email:sales@worldwidemarketreports.com